18 June 2025
Baker McKenzie legal advisor to Xbrane in its primary issuance of shares of approximately SEK 240 million
Advising firms
Deal team
4 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Joakim Falkner | Baker McKenzie | Not stated | capital markets | Not stated |
| Johanna Flink | Baker McKenzie | Not stated | capital markets | Not stated |
| Carl Isaksson | Baker McKenzie | Not stated | capital markets | Not stated |
| Simon Olofsson | Baker McKenzie | Not stated | capital markets | Not stated |
1 more lawyer on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- SEK 240m (approximately SEK 240 million)
- What the figure measures
- Issue size
- Client
- Xbrane Biopharma ABIssuer
- Counterparties
- Not stated